更新于：2024-11-21

Indium In-111 Pentetate Disodium

喷替酸钠铟[111In]

更新于：2024-11-21

概要

概要

基本信息

药物类型

核素偶联药物

别名

Mpi Indium Dtpa In 111

靶点-

作用机制-

治疗领域-

在研适应症-

非在研适应症-

原研机构

GE Healthcare Ltd. (United Kingdom)

在研机构

GE Healthcare Ltd. (United Kingdom)

非在研机构-

最高研发阶段批准上市

首次获批日期

美国 (1982-02-18)

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

结构

分子式C14H18InN3Na2O10

InChIKeyJKGXLBAWNSPIFF-LWQDMHIUSA-I

CAS号60662-14-8

使用我们的ADC技术数据为新药研发加速。

或

查看完整样例数据

关联

100 项与喷替酸钠铟[111In] 相关的临床结果

登录后查看更多信息

100 项与喷替酸钠铟[111In] 相关的转化医学

登录后查看更多信息

100 项与喷替酸钠铟[111In] 相关的专利（医药）

登录后查看更多信息

项与喷替酸钠铟[111In] 相关的文献（医药）

2009-12-01·Journal of Experimental & Clinical Cancer Research1区 · 医学

Carotid body tumors: radioguided surgical approach

1区 · 医学

ArticleOA

作者: Sara Savelli ; Luigi Irace ; Luciano Izzo ; Bruno Gossetti ; Roberto Gattuso ; Ombretta Martinelli ; Fabrizio Benedetti-Valentini ; Fabrizia Giannoni ; Rita Massa

AbstractBackgroundCarotid body tumours (CBTs) are very rare lesions which should be treated as soon as possible even when benign since small tumour size permits easier removal and lower incidence of perioperative complications and recurrence. Malignant forms are rare and they can be identified by lymph node invasion and metastases in distant locations. The need of reliable and effective diagnostic modalities for both primary CBTs and its metastases or recurrence is evident.The present study reviews our experience and attempt to define the role of colour coded ultrasound (CCU) and Somatostatin receptor scintigraphy (SRS) with Indium-111-DTPA-pentetretide (Octreoscan®) using both planar and single photon emission tomography (SPECT) technique in the diagnosis and follow-up of these uncommon lesions within a multidisciplinary approach.MethodsFrom 1997 to 2008, 12 patients suffering from 16 CBTs (4 bilateral) were investigated by CCU and SRS-SPECT before and after surgery. All tumours were grouped according to Shamblin's classification in order to assess the technical difficulties and morbidity of surgical resection on the ground of their size and relationship with the carotid arteries. Intraoperative radiocaptation by Octreoscan®) was also carried out in all cases to evaluate the radicality of surgery. All perioperative scans were evaluated by the same nuclear medicine physician.ResultsPreoperatively CCU showed CBTs (four were not palpable) with a sensitivity of 100%. Radioisotope imaging identified the CBTs as chemodectomas in 15 cases while no radioisotopic uptake was detected in 1 vagus nerve neurinoma. No evidence of metastasis or multicentricity were seen by total body radioisotopic scans. Combined data from CCU and SRS-SPECT allowed to determine tumour size in order to select 7 larger tumours which were submitted to selective preoperative embolization.Intraoperatively Octreoscan demonstrated microscopic tumour leftovers promptly removed in 1 case and an unresectable remnant at the base of the skull in another case.During follow-up CCI and radioisotope scans showed no recurrence in 14 cases and a slightly enlargement of the intracranial residual as detected during surgery in 1 patient.ConclusionCCU may allow an early and noninvasive detection of CBTs and hence safer operations. The combined use of CCU and SRS-SPECT provide useful data to identify those tumours and to evaluate their extent and carotid arteries infiltration. Radioisotope imaging is a sensitive modality to detect metastases and lymph node involvement that are markers of CBT malignancy. After surgery CCU and SRS-SPECT can be accurate modalities for surveillance for an early detection of CBTs recurrence.

1995-12-01·Clinical Endocrinology2区 · 医学

Successful localization of an occult ACTH‐secreting bronchial carcinoid tumour with ¹¹¹indium‐DTPA labelled octreotide

2区 · 医学

Article

作者: Kaskarelis J ; Giannakenas C ; Belenis I ; Platis O ; Tsagarakis S ; Vassilakos Pj ; Rontoyianni D ; Thalassinos N

SummaryEctopic ACTH secretion due to occult carcinoid tumours is an occasional cause of ACTH dependent Cushing's syndrome. In many cases the ectopic source may be obvious, but sometimes no obvious source is evident, the so‐called occult ectopic syndrome. Due to their small size, localization of such occult tumours, particularly bronchial carcinoids, may be extremely difficult. Whole body CT and verious sampling studies have been used but are not always successful in determining the site of such lesions. We report a 40‐year‐old patient with the ectopic ACTH syndrome due to a 0.6‐cm bronchial carcinoid tumour which was successfully localized by 111indium‐DTPA labelled octreotide scintigraphy.

1993-05-01·Annals of the New York Academy of Sciences2区 · 综合性期刊

[¹¹¹In]DTPA‐Labeled Analogues of α‐MSH for the Detection of MSH Receptors In Vitro and In Vivo

2区 · 综合性期刊

Article

作者: B. Stolz ; A. N. Eberle ; C. Bruns ; J. Pless ; C. Bagutti ; R. Albert

[¹¹¹In]DTPA-bis-([Nle⁴,Asp⁵,D-Phe⁷,Lys¹⁰]α-MSH_4-10) and [¹¹¹In]DTPA-bis-([Nle⁴,Asp⁵,D-Phe⁷,Lys(bis-DHP)¹⁰]α-MSH_4-10) when administered to control and melanoma-bearing mice showed a relatively high accumulation in liver and were excreted mainly via the kidneys, and both were potent and specific radioligands for MSH receptors in the melanomas.

100 项与喷替酸钠铟[111In] 相关的药物交易

登录后查看更多信息